1. Home
  2. FNGR vs KZR Comparison

FNGR vs KZR Comparison

Compare FNGR & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FingerMotion Inc.

FNGR

FingerMotion Inc.

HOLD

Current Price

$0.85

Market Cap

50.2M

Sector

Technology

ML Signal

HOLD

Logo Kezar Life Sciences Inc.

KZR

Kezar Life Sciences Inc.

HOLD

Current Price

$7.29

Market Cap

54.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNGR
KZR
Founded
2016
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.2M
54.2M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
FNGR
KZR
Price
$0.85
$7.29
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$6.00
AVG Volume (30 Days)
218.3K
105.5K
Earning Date
05-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
$35,607,614.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$3.53
52 Week High
$5.20
$7.55

Technical Indicators

Market Signals
Indicator
FNGR
KZR
Relative Strength Index (RSI) 35.22 54.64
Support Level $0.81 $7.25
Resistance Level $1.55 $7.47
Average True Range (ATR) 0.07 0.11
MACD -0.02 -0.02
Stochastic Oscillator 19.58 37.50

Price Performance

Historical Comparison
FNGR
KZR

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company's business line includes Telecommunications Products and Services, Value Added Products and Services, Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

About KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Share on Social Networks: